This is the authors' abstract. We don't add key points for this paper.
SUMMARY The long‐term administration of medroxyprogesterone acetate (MPA), 40 mg/day, has not proved to be an effective treatment of acromegaly. It neither stops the growth of the tumour nor adequately suppresses growth hormone secretion and it brings no change in the glucose intolerance and hyperinsulinism.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Josefsberg et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: